PURPOSE: To examine the effects of the menopausal transition and treatment with aromatase inhibitors (AI) on trabecular bone score (TBS, a newly proposed index of bone architecture derived from DXA vertebral scans) and vertebral bone mineral density (BMD). METHODS: Retrospective cohort study on 29 women who became postmenopausal during a mean follow-up of 2.9 years (MP group) and 34 women treated with AI during a mean follow-up of 2.1 years (AI group). BMD was measured by DXA and TBS with a specific software. RESULTS: TBS decreased after menopause, but the change was significantly lower than that of the lumbar BMD (-4.6 vs. -6.8 %; mean difference: 2.2 %; p = 0.016). An even larger difference was observed in the AI group (-2.1 vs. -5.9 %; mean difference: 3.8 %; p = 0.002). CONCLUSIONS: The decrease of TBS induced by menopause or treatment with AI is significantly lower than that of lumbar BMD.
PURPOSE: To examine the effects of the menopausal transition and treatment with aromatase inhibitors (AI) on trabecular bone score (TBS, a newly proposed index of bone architecture derived from DXA vertebral scans) and vertebral bone mineral density (BMD). METHODS: Retrospective cohort study on 29 women who became postmenopausal during a mean follow-up of 2.9 years (MP group) and 34 women treated with AI during a mean follow-up of 2.1 years (AI group). BMD was measured by DXA and TBS with a specific software. RESULTS:TBS decreased after menopause, but the change was significantly lower than that of the lumbar BMD (-4.6 vs. -6.8 %; mean difference: 2.2 %; p = 0.016). An even larger difference was observed in the AI group (-2.1 vs. -5.9 %; mean difference: 3.8 %; p = 0.002). CONCLUSIONS: The decrease of TBS induced by menopause or treatment with AI is significantly lower than that of lumbar BMD.
Authors: Angela M Cheung; Lianne Tile; Savannah Cardew; Sandhya Pruthi; John Robbins; George Tomlinson; Moira K Kapral; Sundeep Khosla; Sharmila Majumdar; Marta Erlandson; Judy Scher; Hanxian Hu; Alice Demaras; Lavina Lickley; Louise Bordeleau; Christine Elser; James Ingle; Harriet Richardson; Paul E Goss Journal: Lancet Oncol Date: 2012-02-07 Impact factor: 41.316
Authors: Joel S Finkelstein; Sarah E Brockwell; Vinay Mehta; Gail A Greendale; MaryFran R Sowers; Bruce Ettinger; Joan C Lo; Janet M Johnston; Jane A Cauley; Michelle E Danielson; Robert M Neer Journal: J Clin Endocrinol Metab Date: 2007-12-26 Impact factor: 5.958
Authors: Barbara C Silva; William D Leslie; Heinrich Resch; Olivier Lamy; Olga Lesnyak; Neil Binkley; Eugene V McCloskey; John A Kanis; John P Bilezikian Journal: J Bone Miner Res Date: 2014-03 Impact factor: 6.741
Authors: A R Hong; J H Kim; K H Lee; T Y Kim; S A Im; T Y Kim; H G Moon; W S Han; D Y Noh; S W Kim; C S Shin Journal: Osteoporos Int Date: 2017-01-12 Impact factor: 4.507